Goyal Jaya
SEC CIK 1922548 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PEPG | PepGen Inc. | EVP, Res, Preclin. Dev | 392 | — | $110.6K | 4 | 2023-02-06 | 2023-03-24 |
Most active insiders at PEPG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA Capital Healthcare Fund LP | Dir, 10% | $30.00M | — |
| 2 | Oxford Science Enterprises plc | Former 10% Owner | $640.0K | — |
| 3 | McArthur James G | Pres, CEO, Dir | — | $32.9K |
| 4 | Donnelly Noel | CFO | — | $13.0K |
| 5 | STRECK PAUL | EVP, Head of R, D | — | $11.7K |
| 6 | Kasraian Kasra | Chief Technical Off | — | $1,739 |
| 7 | Vittiglio Joseph | Chief Business, Legal Off | — | — |
Goyal Jaya made no open-market trades at PEPG in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-28 | 2023-03-24 | PEPG | PepGen Inc. | Goyal Jaya | EVP, Res, Preclin. Dev | M - OptEx | $10.88 | +392 | 392 | New | +$4,265 |
| D | 2023-03-28 | 2023-03-24 | PEPG | PepGen Inc. | Goyal Jaya | EVP, Res, Preclin. Dev | S - Sale+OE | $20.00 | -392 | 0 | -100% | -$7,840 |
| DM | 2023-02-08 | 2023-02-06+ | PEPG | PepGen Inc. | Goyal Jaya | EVP, Res, Preclin. Dev | M - OptEx | $10.88 | +6,000 | 3,679 | New | +$65.3K |
| DM | 2023-02-08 | 2023-02-06+ | PEPG | PepGen Inc. | Goyal Jaya | EVP, Res, Preclin. Dev | S - Sale+OE | $17.12 | -6,000 | 0 | -100% | -$102.7K |
Purchase Sale Sale after option exercise All abbreviations